⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Marker Therapeutics, Inc. Common Stock

$1.11
-0.07 (-6.32%)

Volume:

28.55K ($32.77K)

Market Capitalization:

$18.51M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Marker Therapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

-0.04(-3.47%)
Open$1.15
Close$1.11
Low$1.11
Low Change-0.04 (-3.47%)
High$1.18
High Change+0.03 (+2.61%)
Range$0.07
Volume1.648K
Dollar Volume$1.83K

Regular Trading Hours

-0.07(-5.74%)
Open$1.22
Close$1.15
Low$1.15
Low Change-0.07 (-5.74%)
High$1.22
High Change+0.00 (+0.00%)
Range$0.07
Volume26.902K
Dollar Volume$30.94K

Premarket

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$1.19
Close$1.19
Low$1.19
Low Change0.00 (0.00%)
High$1.19
High Change+0.00 (+0.00%)
Range$0.00
Volume223
Dollar Volume$265.37

Regular Trading Hours Yesterday

-0.07(-5.94%)
Open$1.26
Close$1.19
Low$1.15
Low Change-0.11 (-8.72%)
High$1.31
High Change+0.05 (+3.98%)
Range$0.16
Volume137.59K
Dollar Volume$163.04K

Premarket Yesterday

*No Trades in Segment

Marker Therapeutics News

There is no current news for this stock at the moment.

Marker Therapeutics Top Trades

Marker Therapeutics's top trade so far today returned +2.61%, while the top short trade returned -9.01%.

Marker Therapeutics Moving Averages

5 Day Moving Average (SMA5)$1.21
10 Day Moving Average (SMA10)$1.18
20 Day Moving Average (SMA20)$1.23
50 Day Moving Average (SMA50)$1.23
100 Day Moving Average (SMA100)$1.34
200 Day Moving Average (SMA200)$1.44

Marker Therapeutics Statistics

Average Volume (30 Days)73.08K
P/E Ratio (Current)-2.38
EPS (Current)-$0.52
Dividend Yield0.00%
Free Cash Flow-$9.76M
Cash Ratio4.68
Current Ratio6.03
Quick Ratio6.03
Debt to Equity0.00
Enterprise Value$9.34M
EV to EBITDA-0.87
EV to Sales4.00
Price to Book1.70
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales8.85
Return on Assets-0.60%
Return on Equity-0.72%

Marker Therapeutics Stock Splits

There has been 1 stock split for Marker Therapeutics (MRKR). The reverse stock split occured on January 27, 2023 and reduced the outstanding shares at a ratio of 10:1.

DateTypeRatio
Jan 27, 2023Reverse10:1

Marker Therapeutics Dividends

There have been no dividends for Marker Therapeutics (MRKR).